[BostonCard]

More on the Oxford vaccine.

https://www.nytimes.com/2020/04/27/world...xford.html

Don't get too attached to any one effort, but with enough shots on goal, hopefully one will be successful.

BC

And that's the whole point behind parallel development of manufacturing, hopefully one of these works (we're pretty Fucked-with-a-capital-F if they don't) so you may as well bet on all of them. What do you think the shutdowns cost us, a few hundred billion a month? Every day you gain is worth billions. The ROI here is insane, we should be doing whatever we can to speed it up, if it's at all plausible it should be greenlit.

Almost no matter how you start manufacturing, it will be impossible to have billions of doses ready.  So, there will have to be some way of prioritizing, which usually goes something like:
1) Healthcare workers & emergency responders
2) High risk populations (age > 70, significant co-morbidities)
3) High exposure populations (grocery store clerks, etc.)
4) Moderate risk populations (age > 50, other co-morbidities)
5) Everyone else

BC

[BostonCard]

More on the Oxford vaccine.

https://www.nytimes.com/2020/04/27/world...xford.html

Don't get too attached to any one effort, but with enough shots on goal, hopefully one will be successful.

BC

And that's the whole point behind parallel development of manufacturing, hopefully one of these works (we're pretty Fucked-with-a-capital-F if they don't) so you may as well bet on all of them. What do you think the shutdowns cost us, a few hundred billion a month? Every day you gain is worth billions. The ROI here is insane, we should be doing whatever we can to speed it up, if it's at all plausible it should be greenlit.

Almost no matter how you start manufacturing, it will be impossible to have billions of doses ready.  So, there will have to be some way of prioritizing, which usually goes something like:
1) Healthcare workers & emergency responders
2) High risk populations (age > 70, significant co-morbidities)
3) High exposure populations (grocery store clerks, etc.)
4) Moderate risk populations (age > 50, other co-morbidities)
5) Everyone else

BC